An Interview With Josh Disbrow, CEO of Aytu BioPharma
Larry Luxner, senior correspondent for Rare Disease Advisor, interviews Josh Disbrow, CEO of Colorado-based Aytu BioPharma.
Larry Luxner, senior correspondent for Rare Disease Advisor, interviews Josh Disbrow, CEO of Colorado-based Aytu BioPharma.
Larry Luxner, senior correspondent for Rare Disease Advisor, interviews Ilan Ganot, founder and CEO of Solid Biosciences, based in Cambridge, Massachusetts.
Rare Disease Advisor senior correspondent Larry Luxner interviews DMD expert Jerry Mendell, MD, a professor at Nationwide Children’s Hospital in Columbus, Ohio.
Alagille syndrome (ALGS) is a rare genetic multiorgan disorder. Take our quick quiz on statements about the differential diagnosis of ALGS.
Larry Luxner, senior correspondent for Rare Disease Advisor, interviews Henry Kaminski, MD, on the difficulties of treating myasthenia gravis.
Larry Luxner, senior correspondent for Rare Disease Advisor, talks with Laura McLinn, the Indiana mom of 12-year-old Jordan McLinn, who has Duchenne muscular dystrophy (DMD). Jordan, who became the unofficial poster boy of the “Right to Try” movement, has just completed 5 years in a clinical trial for a novel exon 53 skipping therapy. Read…
Pompe disease, also known as glycogen storage disease type 2, is an autosomal recessive disorder. Take our quick quiz on its etiology.
Larry Luxner, senior correspondent for Rare Disease Advisor, interviews neuropsychiatrist Anthony Feinstein, PhD, a professor at the University of Toronto.
Larry Luxner, senior correspondent for Rare Disease Advisor, interviews Jay Griffin, a North Carolina father of a boy with Duchenne muscular dystrophy.
Larry Luxner, senior correspondent for Rare Disease Advisor, talks with Meredith O’Connor about her efforts to raise awareness of myasthenia gravis.